Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

NCT06606990 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

NIH

Sponsor class

Conditions

Metastatic Malignant Solid Neoplasm

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography Test
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Pidnarulex

Sponsor

National Cancer Institute (NCI)